The Antimicrobial Resistance Diagnostics market is a subset of the Diagnostics industry, focused on the development and commercialization of tests that detect and identify antimicrobial resistance in bacteria. These tests are used to inform treatment decisions and help reduce the spread of drug-resistant infections. The market is driven by the increasing prevalence of antimicrobial resistance, the need for rapid and accurate diagnosis, and the growing demand for point-of-care testing. The market is segmented by product type, technology, end user, and geography. Product types include molecular diagnostics, culture-based diagnostics, and other tests. Technologies include PCR, sequencing, and other methods. End users include hospitals, laboratories, and other healthcare facilities. Notable companies in the Antimicrobial Resistance Diagnostics market include Abbott, Becton Dickinson, bioMérieux, Cepheid, Hologic, and Roche. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
